NASDAQ: CELZCreative Medical Technology Holdings Inc Stock Ownership - Who owns Creative Medical Technology Holdings?
Insider buying vs selling
Have Creative Medical Technology Holdings Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Michael H. Finger | Director | 2025-02-19 | 750 | $5.75 | $4.31kSell |
| Michael H. Finger | Director | 2025-02-18 | 750 | $5.00 | $3.75kSell |
CELZ insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when CELZ insiders and whales buy or sell their stock.
CELZ Shareholders
What type of owners hold Creative Medical Technology Holdings Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Timothy Warbington | 1.35% | 34,904 | $116.40k | Insider |
| Geode Capital Management LLC | 0.81% | 20,876 | $69.62k | Institution |
| Vanguard Group Inc | 0.68% | 17,629 | $58.79k | Institution |
| Northern Trust Corp | 0.45% | 11,707 | $39.04k | Institution |
| Citadel Advisors LLC | 0.43% | 11,145 | $37.17k | Institution |
| Allworth Financial LP | 0.15% | 4,000 | $13.34k | Institution |
| Ameritas Advisory Services LLC | 0.09% | 2,276 | $7.59k | Institution |
| Tower Research Capital LLC Trc | 0.04% | 1,029 | $3.43k | Institution |
| Michael H. Finger | 0.01% | 351 | $1.17k | Insider |
| Bank Of America Corp | 0.01% | 133 | $443.56 | Institution |
CELZ vs Biotech Stocks
Creative Medical Technology Holdings Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.